- Home
- EYPT vs NRC Comparison
EYPT vs NRC Comparison
Compare EYPT & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- NRC
- Stock Information
- Founded
- EYPT 1987
- NRC 1981
- Country
- EYPT United States
- NRC United States
- Employees
- EYPT N/A
- NRC N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- EYPT Industrials
- NRC Health Care
- Exchange
- EYPT Nasdaq
- NRC Nasdaq
- Market Cap
- EYPT 427.9M
- NRC 394.2M
- IPO Year
- EYPT 2005
- NRC N/A
- Fundamental
- Price
- EYPT $6.51
- NRC $10.69
- Analyst Decision
- EYPT Strong Buy
- NRC
- Analyst Count
- EYPT 8
- NRC 0
- Target Price
- EYPT $25.71
- NRC N/A
- AVG Volume (30 Days)
- EYPT 841.5K
- NRC 88.7K
- Earning Date
- EYPT 05-07-2025
- NRC 05-06-2025
- Dividend Yield
- EYPT N/A
- NRC 4.49%
- EPS Growth
- EYPT N/A
- NRC N/A
- EPS
- EYPT N/A
- NRC 1.04
- Revenue
- EYPT $43,273,000.00
- NRC $143,060,000.00
- Revenue This Year
- EYPT N/A
- NRC N/A
- Revenue Next Year
- EYPT N/A
- NRC N/A
- P/E Ratio
- EYPT N/A
- NRC $9.74
- Revenue Growth
- EYPT N/A
- NRC N/A
- 52 Week Low
- EYPT $3.91
- NRC $9.76
- 52 Week High
- EYPT $21.26
- NRC $35.81
- Technical
- Relative Strength Index (RSI)
- EYPT 61.19
- NRC 33.45
- Support Level
- EYPT $5.37
- NRC $9.76
- Resistance Level
- EYPT $5.86
- NRC $11.42
- Average True Range (ATR)
- EYPT 0.57
- NRC 0.99
- MACD
- EYPT 0.20
- NRC -0.06
- Stochastic Oscillator
- EYPT 99.81
- NRC 25.79
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.